Article
SOD2 Expression in Patients with Triple-Negative Breast Cancer is Associated with Tumor-infiltrating Lymphocytes and Prognosis
2025-06-10
Abstract excerpt
<title>Abstract</title> <p>Purpose Superoxide dismutase 2 (SOD2), an antioxidant enzyme, plays a pivotal role in carcinogenesis and immune regulation. In this study, we investigated the expression and implications of superoxide dismutase (SOD2) in triple-negative breast cancer (TNBC), an aggressive subtype with varying immune profiles and clinical outcomes. Methods Multiple TNBC cohorts were analyzed with vario...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 32ae3b75-9c29-5d26-951d-6303bb7145bc
- DOI
- 10.21203/rs.3.rs-6815713/v1
